BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28581490)

  • 1. Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1.
    Matsuda A; Higashi M; Nakagawa T; Yokoyama S; Kuno A; Yonezawa S; Narimatsu H
    Lab Invest; 2017 Sep; 97(9):1103-1113. PubMed ID: 28581490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
    Yonezawa S; Sato E
    Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.
    Masaki Y; Oka M; Ogura Y; Ueno T; Nishihara K; Tangoku A; Takahashi M; Yamamoto M; Irimura T
    Hepatogastroenterology; 1999; 46(28):2240-5. PubMed ID: 10521973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Glycoform Analysis of MUC1 Derived from Biological Specimens Using an Antibody-Overlay Lectin Microarray.
    Matsuda A; Boottanun P; Koizumi S; Nagai M; Kuno A
    Methods Mol Biol; 2024; 2763():223-236. PubMed ID: 38347414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat.
    Takeuchi H; Kato K; Denda-Nagai K; Hanisch FG; Clausen H; Irimura T
    J Immunol Methods; 2002 Dec; 270(2):199-209. PubMed ID: 12379325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma.
    Suzuki H; Shoda J; Kawamoto T; Shinozaki E; Miyahara N; Hotta S; Iizuka Y; Nakahara A; Tanaka N; Yanaka A; Irimura T
    Clin Exp Metastasis; 2004; 21(4):321-9. PubMed ID: 15554388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.
    Matsuda A; Kuno A; Kawamoto T; Matsuzaki H; Irimura T; Ikehara Y; Zen Y; Nakanuma Y; Yamamoto M; Ohkohchi N; Shoda J; Hirabayashi J; Narimatsu H
    Hepatology; 2010 Jul; 52(1):174-82. PubMed ID: 20578261
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Kokubu R; Ohno S; Kuratani H; Takahashi Y; Manabe N; Shimizu H; Chiba Y; Denda-Nagai K; Tsuiji M; Irimura T; Yamaguchi Y
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
    Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
    Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MUC1 recognized by a monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Miyahara N; Suzuki H; Furukawa M; Todoroki T; Tanaka N; Irimura T
    Clin Exp Metastasis; 2004; 21(4):353-62. PubMed ID: 15554392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin Microarray-Based Sero-Biomarker Verification Targeting Aberrant O-Linked Glycosylation on Mucin 1.
    Matsuda A; Kuno A; Nakagawa T; Ikehara Y; Irimura T; Yamamoto M; Nakanuma Y; Miyoshi E; Nakamori S; Nakanishi H; Viwatthanasittiphong C; Srivatanakul P; Miwa M; Shoda J; Narimatsu H
    Anal Chem; 2015 Jul; 87(14):7274-81. PubMed ID: 26091356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
    Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
    Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
    Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
    Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel monoclonal antibody specific for sialylated MUC1 mucin.
    Yamamoto M; Bhavanandan VP; Nakamori S; Irimura T
    Jpn J Cancer Res; 1996 May; 87(5):488-96. PubMed ID: 8641986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T; Shoda J; Irimura T; Miyahara N; Furukawa M; Ueda T; Asano T; Kano M; Koike N; Fukao K; Tanaka N; Todoroki T
    Clin Cancer Res; 2001 May; 7(5):1333-42. PubMed ID: 11350903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
    Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
    Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of MUC mucin in cholangiocarcinoma.
    Mall AS; Tyler MG; Ho SB; Krige JE; Kahn D; Spearman W; Myer L; Govender D
    Pathol Res Pract; 2010 Dec; 206(12):805-9. PubMed ID: 20947262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
    Tang Z; Yang Y; Wang X; Meng W; Li X
    BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
    Matsuda A; Kuno A; Matsuzaki H; Kawamoto T; Shikanai T; Nakanuma Y; Yamamoto M; Ohkohchi N; Ikehara Y; Shoda J; Hirabayashi J; Narimatsu H
    J Proteomics; 2013 Jun; 85():1-11. PubMed ID: 23612463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.